Marine Microbial Ectoine Mitigates Lipoglucotoxic Injury in H9c2 Cardiomyocytes and Activates AMPK

Ectoine is a natural compatible solute known for its cytoprotective properties, though its potential role in alleviating diabetic cardiomyopathy remains largely unexplored. This study aimed to examine the protective effects and underlying mechanisms of Ectoine on H9c2 cardiomyocytes under high-glucose and high-palmitic acid conditions.

The investigation included assessment of cell viability and lactate dehydrogenase release. Oxidative stress was evaluated through measurements of reactive oxygen species, malondialdehyde levels, and superoxide dismutase activity. Inflammatory responses were analyzed via TNF-α secretion and NF-κB and ERK1/2 pathways. Molecular docking studies were conducted to explore Ectoine-AMPK interaction, while mechanistic insights were gained through examination of AMPK signaling, energy metabolism regulators, autophagic flux markers, and mitochondrial apoptosis.

Ectoine treatment was associated with enhanced cell viability and reduced lactate dehydrogenase release. It appeared to alleviate oxidative stress through decreased reactive oxygen species and malondialdehyde levels, along with increased superoxide dismutase activity. Ectoine also showed suppressive effects on inflammatory responses, including reduced TNF-α secretion and inhibited NF-κB and ERK1/2 pathways. Molecular docking suggested binding affinity between Ectoine and AMPK (-6.4 kcal/mol). Mechanistically, Ectoine demonstrated potential in activating AMPK signaling, modulating energy metabolism, restoring autophagic flux, and attenuating mitochondrial apoptosis.

The findings suggest that Ectoine may protect against HG-PA-induced cardiomyocyte injury. This protective effect was associated with AMPK activation and the coordinated modulation of metabolic, autophagic, anti-inflammatory, and anti-apoptotic pathways. This study suggests the therapeutic potential of Ectoine and provides a basis for further investigation.